MEDS halted on Sep 17 2026 at $5.79

THE DAY ON THE LIST · 3 EVENTS

1. 04:02 ET
   MOVER · PRE-MARKET

   $7.49 · ▲ 23.4% ON THE DAY · — 5M RVOL · RANK #8

   ≫STRETCHEDCONFIDENCE5/5

   MEDS is up 18.1% pre-market after a prior circuit-breaker halt and coverage of its Helomics acquisition. The deal provides an acquired subsidiary but was funded with 636,328 shares and a convertible note, so the sharp move is far larger than the disclosed, non-quantified operating news supports and carries clear issuance risk.

   WHYAn 18.1% move, following a reported 311.73% surge, is outsized relative to an acquisition funded by 19.99% in stock and a convertible note rather than a quantified earnings or approval catalyst.

   ANALYZED 04:01 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNA

   THE ROW AND SESSION LEVELS AT 04:02 ET

   LAST7.49

   DAY▲ 23.4%

   5 MIN▲ 9.50%

   5M RVOL—

   5M $VOL$538K

   FLOAT*3.2M

   RANK#8

   SESSIONPRE-MARKET

   VWAP7.44

   HOD8.04

   LOD6.84

   OR HIGH—

   OR LOW—

   PREV CLOSE6.07

   PM HIGH8.04

   PM LOW6.84

   GAP▲ 32.43% (indicated)

   * FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE

   — MEANS THE LEVEL DID NOT EXIST YET AT THAT INSTANT, NOT ZERO

2. 09:32 ET
   HALT · REGULAR

   HALTED AT $5.79 · ▼ 4.6% ON THE DAY · 1.1× 5M RVOL · RANK #20

   ?UNEXPLAINEDCONFIDENCE5/5

   MEDS fell 11.87% in five minutes after previously surging on attention around its Helomics acquisition and related financing. The supplied material contains no new negative catalyst explaining this reversal, while the recent issuance and convertible note create clear dilution risk into volatility.

   WHYA sharp 11.87% five-minute drop is not explained by the supplied news, so order flow is driving the move; the acquisition financing is material but was already disclosed and does not specifically justify this selloff.

   ANALYZED 09:31 ET · <1 MIN AGO · OPENAI/GPT-5.6-LUNA

   THE ROW AND SESSION LEVELS AT 09:32 ET

   LAST5.79

   DAY▼ 4.6%

   5 MIN▼ 12.01%

   5M RVOL1.1×

   5M $VOL$1.4M

   FLOAT*3.2M

   RANK#20

   SESSIONREGULAR

   VWAP6.96

   HOD8.10

   LOD5.79

   OR HIGH6.75

   OR LOW5.79

   PREV CLOSE6.07

   PM HIGH8.10

   PM LOW5.82

   GAP▲ 10.87%

   * FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE

3. 09:42 ET
   UNEXPLAINED MOVE · REGULAR

   $5.07 · ▼ 16.6% ON THE DAY · 1.2× 5M RVOL · RANK #109

   ?UNEXPLAINEDCONFIDENCE5/5

   MEDS is down 4.6% and currently halted, with no fresh downside catalyst identified in the supplied material. The latest substantive filing describes an acquisition funded with 636,328 shares and a convertible note, creating dilution exposure, while the move itself is being driven by order flow after extreme prior volatility.

   WHYA 4.6% decline has no matching new negative news; the prior acquisition financing supports dilution risk but does not explain this immediate move.

   ANALYZED 09:37 ET · 4 MIN AGO · OPENAI/GPT-5.6-LUNA

   THE ROW AND SESSION LEVELS AT 09:42 ET

   LAST5.07

   DAY▼ 16.6%

   5 MIN▼ 3.89%

   5M RVOL1.2×

   5M $VOL$1.3M

   FLOAT*3.2M

   RANK#109

   SESSIONREGULAR

   VWAP6.91

   HOD8.10

   LOD5.25

   OR HIGH6.75

   OR LOW5.79

   PREV CLOSE6.07

   PM HIGH8.10

   PM LOW5.82

   GAP▲ 10.87%

   * FLOAT IS SHARES OUTSTANDING; TRUE FREE FLOAT IS NOT AVAILABLE